Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong
Location status: Recruiting
Location contact
Candy TANG, PC
CONTACT
Molly SC LI, MBBS, MRCP
CONTACT
NCT Number: NCT06295497
Lung cancer screening is currently not recommended in non-smokers due to paucity of evidence. Emerging evidence suggests that first-degree family history is a strong risk factor for lung cancer in Asian non-smokers. In Asia, lack of resource is a major challenge in successful implementation of lung cancer screening. Artificial intelligence (AI) is a promising tool to overcome this resource. In this study, we aim to study the clinical utility and demonstrate the feasibility of using an AI assisted programme for lung cancer screening in Asian non-smokers with a positive family history. This is a single-arm non-randomized lung cancer screening study. 3000 non-smokers, age 50 to 75 year old, with a first-degree family history of lung cancer, will be enrolled. Participants will undergo low does computed tomography (LDCT) of thorax and blood taking at enrolment. LDCT films will be interpreted by AI softwares for presence of lung nodules. Participants with lung nodules will be further investigated and followed up according to the risk of malignancy. The primary endpoint is the prevalence of early-staged lung cancer detected by first-round LDCT thorax in this population.
Interested in participating?
Request Info50 year–75 year
All sexes
Interventional
Not applicable
Hong Kong
Location status: Recruiting
Candy TANG, PC
CONTACT
Molly SC LI, MBBS, MRCP
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients are eligible to be included in the study only if all of the following criteria apply:
Exclusion criteria
Patients who meet any of the following exclusion criteria at screening are not eligible to be enrolled in this study:
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Time frame: 2 years
Contact information is provided by the study sponsor or research team.
Candy TANG, PC
CONTACT
Molly SC LI, MBBS, MRCP
CONTACT
Chinese University of Hong Kong
Other
A Prospective Study on Artificial Intelligence Guided Lung Cancer Screening for High-risk Never Smokers in Hong Kong
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06540196
Bronchial Neoplasms, Carcinoma, Bronchogenic
Hamilton, Ontario, Canada
View Trial DetailsNCT06410300
Lung Cancer, Lung Diseases
Columbia, Missouri, United States
View Trial DetailsNCT01441089
Adnexal Diseases, Breast Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT00034216
Breast Cancer, Breast Diseases
Bethesda, Maryland, United States
View Trial Details